157 related articles for article (PubMed ID: 37077092)
1. Fibrolamellar hepatocellular carcinoma presenting as cholestatic jaundice: An unusual presentation of a rare disease.
Singh A; Goyal S; Mehta V; Kakkar C; Narang V; Sood A
Indian J Pathol Microbiol; 2023; 66(2):385-387. PubMed ID: 37077092
[TBL] [Abstract][Full Text] [Related]
2. Case Report of Fibrolamellar Hepatocellular Carcinoma in A 15-Year-old Male.
Alsadery HA; Almaiman H; Alibrah R; Mnayan M; Alblowi A; Alzayyat R; Alshahrani A
Med Arch; 2022 Oct; 76(5):387-390. PubMed ID: 36545449
[TBL] [Abstract][Full Text] [Related]
3. Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma.
Albaugh JS; Keeffe EB; Krippaehne WW
Dig Dis Sci; 1984 Aug; 29(8):762-7. PubMed ID: 6086253
[TBL] [Abstract][Full Text] [Related]
4. Fibrolamellar carcinoma as a cause of bile duct obstruction.
Eckstein RP; Bambach CP; Stiel D; Roche J; Goodman BN
Pathology; 1988 Oct; 20(4):326-31. PubMed ID: 2853861
[TBL] [Abstract][Full Text] [Related]
5. Obstructive jaundice due to intraductal tumour thrombus in recurrent hepatocellular carcinoma: what is the optimal therapeutic approach?
Xin KY; Yee LS; Yong TT; Fui AC
Hepatogastroenterology; 2014 Oct; 61(135):1863-6. PubMed ID: 25713879
[TBL] [Abstract][Full Text] [Related]
6. Extra-hepatic hepatocellular carcinoma presenting as obstructive jaundice.
Batsis JA; Halfdanarson TR; Pitot H
Dig Liver Dis; 2006 Oct; 38(10):768-71. PubMed ID: 16243009
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma presenting with obstructive jaundice.
Lai EC; Lau WY
ANZ J Surg; 2006 Jul; 76(7):631-6. PubMed ID: 16813631
[TBL] [Abstract][Full Text] [Related]
8. Acute pancreatitis and obstructive jaundice as initial complaints of hepatocellular carcinoma: case report.
Jiang GQ; Qian JJ; Yao J; Jin SJ; Bai DS
World J Surg Oncol; 2014 Jan; 12():13. PubMed ID: 24422982
[TBL] [Abstract][Full Text] [Related]
9. Unusual presentation of recurrent hepatocellular carcinoma as obstructive jaundice 15 years after liver transplant.
Camci C; Gurakar A; Kohli V; Sharma S; Jabbour N
Exp Clin Transplant; 2007 Dec; 5(2):713-5. PubMed ID: 18194129
[TBL] [Abstract][Full Text] [Related]
10. The endoscopic retrograde cholangiopancreatographic manifestations of histopathologically diagnosed hepatocellular carcinoma with obstructive jaundice.
Zhao Q; Gong B; Lu N; Liu N
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(3):237-40. PubMed ID: 12658815
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma.
Samdanci ET; Akatli AN; Soylu NK
J Gastrointest Cancer; 2020 Dec; 51(4):1187-1192. PubMed ID: 32860202
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
Kakar S; Burgart LJ; Batts KP; Garcia J; Jain D; Ferrell LD
Mod Pathol; 2005 Nov; 18(11):1417-23. PubMed ID: 15920538
[TBL] [Abstract][Full Text] [Related]
13. Fibrolamellar hepatocellular carcinoma presenting with obstructive jaundice. A report of two cases.
Soyer P; Roche A; Levesque M
Eur J Radiol; 1991; 13(3):196-8. PubMed ID: 1661675
[No Abstract] [Full Text] [Related]
14. Obstructive jaundice caused by hepatocellular carcinoma. Report of three cases.
Afroudakis A; Bhuta SM; Ranganath KA; Kaplowitz N
Am J Dig Dis; 1978 Jul; 23(7):609-17. PubMed ID: 210657
[TBL] [Abstract][Full Text] [Related]
15. A rare cause of obstructive jaundice in a patient with hepatocellular carcinoma.
Ryou SY; Sung PS
Dig Liver Dis; 2022 Dec; 54(12):1721-1722. PubMed ID: 35999137
[No Abstract] [Full Text] [Related]
16. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
[TBL] [Abstract][Full Text] [Related]
17. Bile duct tumour thrombosis: hepatocellular carcinoma presenting with obstructive jaundice.
Dave MS; Mobarak S; Tarazi M; Satyadas T
Br J Hosp Med (Lond); 2021 Aug; 82(8):1. PubMed ID: 34431344
[No Abstract] [Full Text] [Related]
18. Fibrolamellar carcinoma presenting as a pancreatic mass: case report and review of the literature.
Thirabanjasak D; Sosothikul D; Mahayosnond A; Thorner PS
J Pediatr Hematol Oncol; 2009 May; 31(5):370-2. PubMed ID: 19415023
[TBL] [Abstract][Full Text] [Related]
19. Tumor fragment impacted at the major duodenal papilla causing obstructive jaundice in a patient with hepatocellular carcinoma.
Kobayashi N; Kirikoshi H; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Yoneda K; Akiyama T; Fujita K; Yoneda M; Takahashi H; Abe Y; Inamori M; Kubota K; Saito S; Ueno N; Nakajima A
Gastrointest Endosc; 2008 Nov; 68(5):999-1000; discussion 1000. PubMed ID: 18640678
[No Abstract] [Full Text] [Related]
20. Obstructive jaundice caused by hepatocellular carcinoma.
Joehl RJ; Abt AB
J Surg Oncol; 1984 Oct; 27(2):80-4. PubMed ID: 6090814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
